Janssen (ring a bell?) then Amgen Head of Biologics (Amgen is bigger than the largest ASX listed company) - this is a serious hitter. Another ex Amgen in oncology and recently involved directly with PYC. Drug development expertise and connections all over the world for both. Biggest reason I am excited is that people of this calibre only lend their names to Boards when they are pretty sure of success. PYC set out a strategy of drug devlopment on a global scale and have attracted global quality Board members who know the inside of PYC.
Frankly these guys are about 2 notches above what I would expect PYC to be able to attract.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.020(1.59%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.28 | $1.24 | $46.67K | 37.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15857 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |